Targeted temperature management in acute liver failure: A systematic review
Open Access
- 29 June 2020
- journal article
- review article
- Published by Wiley in Nursing in Critical Care
- Vol. 27 (6) , 784-795
Abstract
Background: Targeted temperature management is the modern term for therapeutic hypothermia, where cooling is induced by intensive care clinicians to achieve body temperatures below 36°C. Its use in acute liver failure to improve refractory intracranial hypertension and patient outcomes is not supported by strong quality evidence.Aim: This systematic review aims to determine if targeted temperature management improves patient outcome as opposed to normothermia in acute liver failure.Methods: A computerized and systematic search of six academic and medical databases was conducted using the following keywords: “acute liver failure", “fulminant hepatic injury", “targeted temperature management", “therapeutic hypothermia", and “cooling". Broad criteria were applied to include all types of primary observational studies, from case reports to randomized controlled trials. Standardized tools were used throughout to critically appraise and extract data.Findings: Nine studies published between 1999 and 2016 were included. Early observational studies suggest a benefit of targeted temperature management in the treatment of refractory intracranial hypertension and in survival. More recent controlled studies do not show such a benefit in the prevention of intracranial hypertension. All studies revealed that the incidence of coagulopathy is not higher in patients treated with targeted temperature management. There remains some uncertainty regarding the increased risk of infection and dysrhythmias. Heterogeneity was found between study types, design, sample sizes, and quality.Conclusion: Although it does not significantly improve survival, targeted temperature management is efficient in treating episodes of intracranial hypertension and stabilizing an unstable critical care patient without increasing the risk of bleeding. It does not, however, prevent intracranial hypertension. Data heterogeneity may explain the contradictory findings.Relevance to Clinical Practice: Controlled studies are needed to elucidate the true clinical benefit of targeted temperature management in improving patient outcome.Keywords
This publication has 33 references indexed in Scilit:
- Therapeutic hypothermia in the management of acute liver failureNeurochemistry International, 2012
- Systematic review: acute liver failure – one disease, more than 40 definitionsAlimentary Pharmacology & Therapeutics, 2012
- Therapeutic Hypothermia for Treatment of Intractable Intracranial Hypertension After Liver TransplantationAmerican Journal of Critical Care, 2011
- 56 THE PROPHYLACTIVE EFFECT OF MILD HYPOTHERMIA TO PREVENT BRAIN EDEMA IN PATIENTS WITH ACUTE LIVER FAILURE: RESULTS OF A MULTICENTER RANDOMIZED, CONTROLLED TRIALJournal of Hepatology, 2011
- Hypothermia and Protection from Acetaminophen-Induced Liver InjuryTherapeutic Hypothermia and Temperature Management, 2011
- Prolonged Hypothermia as a Bridge to Recovery for Cerebral Edema and Intracranial Hypertension Associated with Fulminant Hepatic FailureNeurocritical Care, 2009
- Therapeutic Hypothermia for Acute Liver Failure: Toward a Randomized, Controlled Trial in Patients with Advanced Hepatic EncephalopathyNeurocritical Care, 2008
- Moderate hypothermia prevents cerebral hyperemia and increase in intracranial pressure in patients undergoing liver transplantation for acute liver failureTransplantation, 2003
- Restoration of Cerebral Blood Flow Autoregulation and Reactivity to Carbon Dioxide in Acute Liver Failure by Moderate HypothermiaHepatology, 2001
- Induced hypothermia in the management of cerebral oedema secondary to fulminant liver failureClinical Transplantation, 1999